Clinical practice. Barrett's esophagus.

Copyright © 2009 Massachusetts Medical Society. A 56-year-old obese man with long-standing gastroesophageal reflux who recently received a diagnosis of Barrett’s esophagus presents for a follow-up visit. He has been taking omeprazole at a dose of 20 mg twice daily and currently has no symptoms of reflux. He has no dysphagia or weight loss. Endoscopic and histopathological examinations show a 4-cm segment of Barrett’s esophagus without dysplasia. How should Barrett’s esophagus be managed?

[1]  L. Gossner,et al.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.

[2]  R. Fitzgerald,et al.  Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  R. Hawes,et al.  Detection of Metaplasia (IM) and Neoplasia in Patients with Barrett's Esophagus (BE) Using High-Definition White Light Endoscopy (HD-WLE) Versus Narrow Band Imaging (NBI): A Prospective, Multi-Center, Randomized, Crossover Trial , 2009 .

[4]  Patricia L. Blount,et al.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.

[5]  SSAT patient care guidelines. Management of Barrett's esophagus. , 2007, Journal of Gastrointestinal Surgery.

[6]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[7]  R. Sampliner,et al.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Michael B Wallace,et al.  Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. , 2008, Gastroenterology.

[9]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[10]  R. Kiesslich,et al.  In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[12]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[13]  D. Sautereau,et al.  French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus , 2007, Endoscopy.

[14]  H. El‐Serag,et al.  Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. , 2008, Gastrointestinal endoscopy.

[15]  A. Chak,et al.  Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends , 2009, The American Journal of Gastroenterology.

[16]  R. K. Pearson.  Radiofrequency Ablation in Barrett's Esophagus with Dysplasia , 2009 .

[17]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[18]  J. Jankowski,et al.  Chemoprevention of oesophageal cancer and the AspECT trial. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[19]  Noel S Weiss,et al.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.

[20]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[21]  J. Johansson,et al.  Metaplastic Columnar Mucosa in the Cervical Esophagus After Esophagectomy , 2002, Annals of surgery.

[22]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[23]  J. Goldblum,et al.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.

[24]  C. Ell,et al.  Medical or Surgical Management of GERD Patients with Barrett’s Esophagus: The LOTUS Trial 3-Year Experience , 2008, Journal of Gastrointestinal Surgery.

[25]  Govind Bhagat,et al.  EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[26]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[27]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[28]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[29]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[30]  G. Block,et al.  Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. , 2009, Gastroenterology.

[31]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[32]  O. Cummings,et al.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.

[33]  Prateek Sharma,et al.  How to manage a Barrett's esophagus patient with low-grade dysplasia. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[35]  R. Fitzgerald.  Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  R. Sampliner,et al.  Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. , 1997, The American journal of gastroenterology.

[37]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[38]  P. Kahrilas.  Clinical practice. Gastroesophageal reflux disease. , 2008, The New England journal of medicine.

[39]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[40]  V. Konda,et al.  Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  D. Armstrong.  Gastroesophageal reflux disease. , 2005, Current opinion in pharmacology.

[42]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[43]  N. Shaheen,et al.  Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis , 2003, American Journal of Gastroenterology.

[44]  B. Shadbolt,et al.  Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus , 2004, The Medical journal of Australia.